Cargando la página…
Cada registro con su número de medicamentos y algunos de ellos.
Menciona dos o más medicamentos y Osler comprueba sus interacciones. Una interacción grave aparece al principio de la respuesta.
Anvisa · 13 medicamentos
PHARMAC · 6 medicamentos
CBG-MEB · 4 medicamentos
AIFA · 3 medicamentos
AEMPS · 1 medicamento
MS · 1 medicamento · Lista histórica
Todos los registros, página a página. Las dosis y los envases están en la página de cada medicamento.
18 resultados
| Medicamento | Registro | Dosis | Forma | Estado | Titular |
|---|---|---|---|---|---|
| Clonidine | Estados Unidos | 0.1MG/24HR, 0.2MG/24HR, 0.3MG/24HR | system | Comercializado | Actavis Labs Ut INC |
| Clonidine | Estados Unidos | 0.09MG BASE/ML | suspension, extended release | No comercializado | Tris Pharma INC |
| Clonidine Hydrochloride | Estados Unidos | 0.1MG, 0.2MG | tablet, extended release | Comercializado | Novast Labs |
| Clonidine Hydrochloride | Estados Unidos | 1MG/10ML, 5MG/10ML | injectable | Comercializado | Fresenius Kabi USA |
| Clonidine Hydrochloride | Estados Unidos | 0.05MG, 0.1MG, 0.2MG … | tablet | Comercializado | Watson Labs |
| Clonidine Hydrochloride and ChlorthalidoneCombinación | Estados Unidos | 15MG; 0.1MG, 15MG; 0.2MG, 15MG; 0.3MG | tablet | No comercializado | Par Pharm |
| Duraclon | Estados Unidos | 1MG/10ML, 5MG/10ML (0.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Comercializado | Mylan Institutional |
| Nexiclon XR | Estados Unidos | 0.17MG BASE, 0.26MG BASE | tablet, extended release | Comercializado | Rosemont |
| Catapres-TTS-1 | Estados Unidos | 0.1MG/24HR | system | Comercializado | Lavipharm |
| Catapres-TTS-2 | Estados Unidos | 0.2MG/24HR | system | Comercializado | Lavipharm |
| Catapres-TTS-3 | Estados Unidos | 0.3MG/24HR | system | Comercializado | Lavipharm |
| Onyda XR | Estados Unidos | 0.1MG/ML | suspension, extended release | Comercializado | Tris Pharma INC |
| Javadin | Estados Unidos | 0.02MG/ML | solution | Comercializado | Azurity |
| Catapres | Estados Unidos | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Boehringer Ingelheim |
| Jenloga | Estados Unidos | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release | No comercializado | Concordia Pharms INC |
| Kapvay | Estados Unidos | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release | No comercializado | Concordia Pharms INC |
| ClorpresCombinación | Estados Unidos | 15MG; 0.1MG, 15MG; 0.2MG, 15MG; 0.3MG | tablet | No comercializado | Natco Pharma |
| CombipresCombinación | Estados Unidos | 15MG; 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG; 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG; 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | No comercializado | Boehringer Ingelheim |
La misma marca en varios registros.
Los laboratorios titulares de sus medicamentos, primero los mayores.
Principios activos con los que comparte medicamento.
Cómo lo escriben los registros, en su propio idioma.
Recopilado por Prognia a partir de los registros públicos de medicamentos de AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, MS y PHARMAC. La página de cada medicamento indica su propia fuente, licencia y atribución.
Notificar un error o solicitar la retiradaLas correcciones de un registro o un laboratorio son bienvenidas.
Para consulta y aprendizaje, no es una recomendación de tratamiento. Consulta siempre la información oficial del producto.
